The Causes of Autism

August 30, 2026

The “Immortal Life” of the Section-on-Vaccine-Package-Inserts that states the Vaccine has not been evaluated for Genotoxicity or Carcinogenicity

Vaccine package inserts on the U.S. Government’s FDA website directly indicate U.S. Government-employees from the FDA/NIH/CDC and the current Secretary of HHS Robert F. Kennedy Jr. cannot scientifically defend the claim that vaccines do not mutate/damage genes and/or result-in/increase-the-risk of cancer(s) [11-117].

FDA package inserts altogether without mention of mutagenic/carcinogenic clinical trials: BCG, Pneumovax, and the 2 Varivax inserts [114-117].

Non-FDA package inserts for polio vaccines also do not mention having conducted mutagenic/carcinogenic safety tests to assure of the genetic-safety of these vaccines [124-127].

In 1996, the FDA recommended genotoxicity safety tests for biological products, which includes vaccines [128].

However, in 2006, FDA withdrew the recommendation for genotoxicity safety tests for vaccines [129].

The World Health Organization states that genotoxicity safety tests are not needed for vaccines via citing their 2005 publication [131].

However, the WHO 2005 publication provides no scientific support for the claim that vaccines are genetically-safe, nor scientific support for the recommendation against such safety tests [130].

In 1996, medical microbiology literature already discussed that viral infection can be genotoxic, that disease can result from sufficient viral replication, and that virus strains that replicate poorly at fever temperature are used for live-virus vaccines [132-134].

The National Childhood Vaccine Injury (NCVI) Act of 1986 provides vaccine manufacturers immunity from liability for “injury or death,” directly stating so dozens of times [7].

The Public Readiness and Emergency Preparedness (PREP) Act provides immunity liability for ‘injury or death’ [119].

An official CDC website page states ‘serious injury or death’ may be a consequence of 26 vaccines [123].

In Chapter 40, Robert F. Kennedy Jr. discusses the Henry Kissinger’s population control report [1, 8].

Comprehension Mindmap- Text Format

• Biological Warfare
  • 1975- Internationally banned upon ratification of the Geneva Protocol and signing Biological Weapons Convention.
    • Pending research question for the current Secretary of HHS: Can U.S. Department of State conduct “reports” on international “compliance” with the treaty when U.S. Government -as per his own research published in this book- continued biological weapons research/development even after ratification of the treaties?
  • Vaccine Research
    • Regarded in the entire book by Robert F. Kennedy Jr. as bioweapons research after the banning of biological weapons research and development.
    • Vaccines were developed to address a “blowback” effect from using biological weapons in war (i.e., soldiers were contracting the diseases that were used against the opponents).
  • Gain-of-Function Research
    • Regarded in the entire book by Robert F. Kennedy Jr. as bioweapons research, and he quotes GOF researchers such as Ralph Baric specifically making statements on how their GOF research contributes to bioweapons research.
• Historical Biolab Incidents
  • 1950s- HIV; RFK Jr. references a London Times article from 1987 regarding a contaminated smallpox vaccine that resulted in HIV infection across the continent of Africa.
    • Utilization of bonobo-chimpanzee kidney culture in development of Plotkin and Koprowski’s oral polio vaccine, with HIV virus being originated in the bonobo.
  • 2013-2020- 9 incidents of infected lab mice escapes; 6 employee exposures to coronaviruses after 2015; 28 accidents involving genetically engineered coronaviruses; mouse bites; from Ralph Baric’s lab which has received over 186 grants from NIAID
  • 2003 (September)- SARS; Singapore lab leak
  • 2003- (December)- SARS; Taiwan lab leak
  • 2004- SARS-CoV; Chinese Institute of Virology in Beijing
  • 2014- SARS; 2,349 vials disappeared from Paris/ Institut Pasteur
  • Spanish flu, anthrax, RSV, pneumonic plague, typhoid, etc.
    • Chapter 27 provides a preliminary quantification of biolab incidents, although there remains a lot of missing data (numbers infected, deaths, etc.).
• Geneva Protocol and Biological Weapons Treaty (BWC)
  • Ratified in 1975; an international treaty to cease biological weapons development.
    • Jump to 2025- U.S. Department of State published a “report” where they state Russia and the People’s Republic of Korea are in violation of the BWC, is “concerned” about Iran….but in regards to China apparently “the United States does not have sufficient information to determine whether China has fulfilled its BWC obligation to eliminate its assessed historical biological warfare program, as required under Article II of the Convention.” [4]
      • Jump to June-2026- Office of the Director of National Intelligence published a report regarding U.S. Government funding of biological weapons research in Ukraine [6].
        • My pending research question for the current Secretary of HHS: Per documents released in June 2026 regarding the U.S. Government funding of biological weapons labs in Ukraine [6], what are the implications for the authority-structure of the government for the People of the United States of America if the U.S. Department of State in their 2025 publication does not address U.S. Government funding of bioweapons research in Ukraine [6] nor addresses Ukraine altogether as a country in their assessment of international adherence to the BWC [4], and states they do not have “sufficient information” on China to determine if they are in “compliance” [4]?
• Patriot Act
  • The method through which biological weapons research/development/production bypasses the Geneva Protocol/Biological Weapons Convention.
  • The Act was passed after the anthrax attacks post-9/11/2001.
    • However, the anthrax-strain was linked back to the Ames, Iowa strain of anthrax, and the FBI ordered the destruction of all their cultures [1].
    • Project Bacchus- the Pentagon had begun cultivating anthrax cultures prior to the “attacks” [1].
• Population Control
  • Henry Kissinger’s report on population control [8]. An official U.S. Government (USAID) report on population control that was declassified.
    • Sterilization of men and women [8]
      • UNFPA- forced sterilization promoted by Indian government
      • WHO/UNICEF- tetanus vaccination program in Kenya
    • Fertility [8]
    • Contraceptives [8]
    • Injectable contraceptives [8]
    • Least Developed Countries (LDCs) [8]
      • “Note: In 2021, the US donated COVID vaccines to the following countries: Pakistan, Bangladesh, the Philippines, Columbia, Indonesia, Nigeria, Brazil, Thailand” (pg. 259) [1]
        • I, a Person of the United States of America operating under the alias Autism Librarian, state to the international community “[no] consent from [We the People] the governed” was obtained on matters of population control taken by U.S. Government or universities-working-with-U.S.-Government or WHO or UNFPA or Bill and Melinda Gates Foundation against People of the United States of America much less actions on population control impacting another country that may subsequently impact the benefits we receive from Our Constitution of the United States of America as concerns international peaceful relations. I am deeply sorry, embarrassed, and ashamed of U.S. Government’s actions on population control, especially regarding the current Secretary of HHS’s reference to U.S. Government donations of Covid vaccines given to aforesaid nations in the context of population control and the Kissinger report.
• Logical Fallacies
  • Appeal to Authority
    • A method referenced by the current Secretary of HHS that was used to appeal to people that the Covid virus was natural in origin, based upon the conclusions of “scientists of multiple countries” [1].
  • Appeal to Unity
    • A method referenced by the current Secretary of HHS that was used to appeal to people that the Covid virus was natural in origin and that scientists should stand in “solidarity” to condemn “conspiracy theories” [1].
  • False Cause
    • I hypothesize False Cause Fallacy is being committed by the CDC and WHO when claims are made regarding cases of a disease for which there are live vaccines that may result in disease-transmission as a consequence of vaccination, supported by transmission statements on vaccine package inserts [155].
    • I hypothesize False Cause Fallacy is being committed by the CDC when “Breakthrough Infection” is not properly defined as resulting from a live-vaccine itself when the CDC Pink Book states there is a probability of disease from the live-vaccine and the infection is utilized as a means of marketing the necessity for live-vaccines [155].
  • Wicked Circle
    • I hypothesize Wicked Circle Fallacy is being committed by the CDC when anti-body titer is utilized/blamed as a culprit for “Breakthrough Infections” without proper definition of the origin/cause of infection which may have been from the vaccine itself, supported by the CDC Pink Book statements that a person may contract the disease from the live-vaccine, and vaccine package insert statements [155]
    • I hypothesize Wicked Circle Fallacy is being committed by the CDC when there is a statement on the ProQuad MMR vaccine package inserts contraindicating products that could interfere with viral replication from the vaccine [77-80], the CDC contraindicates antivirals and antibacterials for various live-vaccines such as Varicella and Typhoid [156], viruses that replicate poorly at fever temperature are used in live-virus vaccines [134], yet fever-reducing medications are not contraindicated for live-vaccines when a 1996 medical microbiology literature states viral infection can be genotoxic [132], which can lead to statements/conclusions that fever-reducing medications taken after live-vaccine administration may be facilitating viral replication to increase the probability of genotoxicity.
    • I hypothesize Wicked Circle Fallacy is being committed by the CDC/NIH/FDA U.S. Government Employees via statements that a live-virus vaccine can prevent transmission yet package inserts on the FDA website simultaneously support the statement that a live-vaccine can result in transmission of the vaccine virus, where transmission should only be possible if a person has the disease they were vaccinated against/for [155]; which also brings this matter to False Cause Fallacy.
• The People of the United States of America seeking Benefits/Protections from the Constitution of the United States of America
  • My pending research question for the current Secretary of HHS: What implications does Robert F. Kennedy Jr. have for U.S. Government-employees’ intelligence beneficial for the People of the United States of America in the context of his inclusion of Chapter 40 regarding the USAID, CIA, and U.S. Department of State’s “Kissinger Report” on population control [1, 8] where ‘forced-sterilization’ methods, such as Robert F. Kennedy Jr.s inclusion of Covid-19 vaccines in Chapter 40 and reference to their shipping to many countries mentioned in the Kissinger Report [1, 8], may be regarded by a Person of the United States of America as infringing upon “Secure[ing] the Blessings of Liberty to Ourselves and Our Posterity,” where U.S. Government methods of forced-sterilization infringe upon a Person’s ability to secure offspring-Posterity?
  • My pending research question for the current Secretary of HHS: When a Person of the United States of America conducts research that may be beneficial/protective to the People of the United States of America and may assist People in earning/obtaining the benefits/protections of the Constitution of the United States of America as concerns natural rights such as Life and Liberty via good-health, where ‘death’ is not Life and where ‘injury or death’ as a consequence of a U.S. Government-created/approved stimuli/stimulus (e.g., lab-GOF-virus, lab-attenuated virus, vaccine, etc.) -whether ‘sub-cellular injury,’ ‘cellular-injury,’ ‘genetic-injury,’ or other ‘injury-form’- infringes upon the protections/benefits provided by the Constitution of the United States of America to a Person (e.g., personal-General Welfare, residential-Domestic Tranquility, Liberty via good-health, offspring-Posterity, etc.), what is the duty/responsibility of a U.S. Government-employee (e.g., President, Secretary of HHS, FDA Commissioner, CDC Director, NIH Director, etc.) in abiding by their Oath of Office to the Constitution of the United States of America in order to maintain their employment?
• A Possible New Addition to the “Cast of Characters” provided at the end of the book
  • Robert F. Kennedy Jr.
    • 2005- Published in Rolling Stone an article on what is now known as the “Simpsonwood Scandal” regarding the CDC covering up the thimerosal-autism research finding [2].
    • 2023- “New York Times Bestselling Author” of ‘The Wuhan Cover-Up and the Terrifying Bioweapons Arms Race’ [1], and co-author of major vaccine book regarded as a culmination of his own research. [2]
      • When Robert F. Kennedy Jr. published his major book on vaccines in 2023, he did not discuss Non-Clinical Toxicology sections of vaccine package inserts [2].
        • Vaccine package inserts on the FDA U.S. Government website directly indicate U.S. Government-employees from the FDA/NIH/CDC and the current Secretary of HHS Robert F. Kennedy Jr. cannot scientifically defend the claim that vaccines do not mutate/damage genes or result-in/increase-the-risk of cancer(s) [11-117].
          • FDA package inserts altogether without mention of mutagenic/carcinogenic clinical trials: BCG, Pneumovax, and the 2 Varivax inserts [114-117].
          • Non-FDA package inserts for polio vaccines also do not mention having conducted mutagenic/carcinogenic safety tests to assure of the genetic-safety of these vaccines [124-127].
          • If U.S. Government-employees make claims that vaccines are genetically safe, they should be asked for the scientific study to support the claim.
        • In 1996, the FDA recommended genotoxicity safety tests for biological products, including vaccines [128]. However, in 2006, FDA withdrew the recommendation for genotoxicity safety tests for vaccines [129]. The World Health Organization states that genotoxicity safety tests are not needed for vaccines via citing their 2005 publication [131], however, the WHO 2005 publication provides no scientific support for the claim that vaccines are genetically safe, nor scientific support for the recommendation against such safety tests [130].
        • In 1996, the medical microbiology literature already discussed that viral infection can be genotoxic, that disease can result from sufficient viral replication, and that virus strains that replicate poorly at fever temperature are used for live-virus vaccines [132-134].
        • The National Childhood Vaccine Injury (NCVI) Act of 1986 provides vaccine manufacturers immunity from liability for “injury or death,” directly stating so dozens of times [7].
          • The Public Readiness and Emergency Preparedness (PREP) Act provides immunity liability for ‘injury or death’ [119].
            • An official CDC website page states ‘serious injury or death’ may be a consequence of 26 vaccines [123].
    • 2024- Presidential candidate…but ended up requesting his supporters to vote for Donald Trump.
      • Will he attempt to run for President again?
    • February 2025- New Secretary of Health and Human Services
      • Jump to July 2026- Apparently condones Gain-of-Function research if it falls into the “Permissible” category that is not very distinguishable from the “Prohibited” category….and he apparently calls vaccine-research “life-saving” in 2026 [9] despite his prior major publications [1-2].
      • Jump to July 2026- HHS Press Release that President Donald Trump previously directed Robert F. Kennedy Jr. to collaborate with Gavi, The Vaccine alliance, also announcing that U.S. Government will be providing $600 million in funds to GAVI [118] despite Robert F. Kennedy Jr.’s publication on vaccine research conducted under the guise of bioweapons research [1] and vaccinated-unvaccinated health outcome studies he compiled [2].
      • Jump to August 2026- President Donald Trump signs an executive order regarding vaccines [152].
        • “Further, it is the policy of my Administration that Federal programs and funding should support maximal parental choice over childhood vaccines, consistent with the Federal Government’s constitutional and statutory obligations and the fundamental principles of personal autonomy and informed consent” [152].
          • Pending research question for the current Secretary of HHS: What implications does Robert F. Kennedy Jr. have regarding informed consent in regards to the lack of mutagenic and carcinogenic clinical trials stated on the Non-Clinical Toxicology sections of vaccine package inserts [11-117]
        • “…offer options to administer core childhood vaccines, starting with MMR, as single vaccines rather than combination products/doses, including by working with the private sector and other countries as appropriate, while guaranteeing continued availability of combination vaccines and those vaccines recommended for shared clinical decision-making; …” [152]
          • Pending research question for the current Secretary of HHS: What implications does the current Secretary of HHS have for U.S. Government health agencies actions as a consequence of the executive order [152] that result in creating new data pools to ensure that conclusions from a new dataset are understood to not have external validity to different environmental conditions (e.g., if subset of people receive vaccines with longer intervals in-between vaccines, conclusions from that data, especially claims of “safety,” should not be applied toward the groups that received a tighter vaccine schedule)?
            • Non-Exhaustive List of Data Pool Examples not without Inter-Connectivity:
              • 1930s-2001- Prior to removal of Thimerosal from childhood vaccines after 2001
                • Reference should be made here to Robert F. Kennedy Jr.’s discussion of the Simpsonwood Scandal in Chapter 3 of Vax-Unvax [2].
              • 1961-2000- Prior to live-polio vaccines no longer being authorized in the USA
              • Prior to 1986- Fewer vaccines per person prior to the passing of the National Childhood Vaccine Injury Act [7]
              • 1900-1978- African American rates of autism prior to MMR vaccine approval [3]
              • 1986-2026- Shorter intervals between vaccines after the passing of the National Childhood Vaccine Injury Act [7] prior to the passing August 2026 Executive Order
                • “…assess the ideal timing and sequencing of all core childhood vaccines and adjust the Federal childhood and adolescent vaccine schedule as appropriate based on gold‑standard science;…” [152]
              • 1978-post-2026- MMR vaccine data analysis prior tochanging the deliverance of the attenuated viruses in separate vaccines
                • “…offer options to administer core childhood vaccines, starting with MMR, as single vaccines rather than combination products/doses, including by working with the private sector and other countries as appropriate, while guaranteeing continued availability of combination vaccines and those vaccines recommended for shared clinical decision-making;…[152]
              • 1930s-post-2026- Prior to the changing/development of new adjuvants to replace aluminum adjuvants
                • “develop additional alternative adjuvants to aluminum and conduct comparative safety and efficacy studies;…” [152]
          • …”ensure continuous evaluation of the risk/benefit profiles of all childhood vaccines based on United States and international data; …” [152]
            • Pending research question for the current Secretary of HHS: What is the risk of genotoxicity/carcinogenicity of single, multiple, and cumulative administrations of vaccines as per the statement of “ensure[ing] continuous evaluation of the risk”?
            • Pending research question for the current Secretary of HHS: When the National Childhood Vaccine Injury Act and Public Readiness and Emergency Preparedness Act
• Universities
  • Harvard Medical School, Cornell, University of Cincinnati, Michigan State College, Northwestern University, Notre Dame, John Hopkins, Yale, Rockefeller Institute, University of Chicago, University of Wisconsin, UC Berkeley
    • “Universities, thus, played a key role in the bioweapons development from the onset. Their reliance on federal scientific research funding now accounts for some 60 percent of university research -far eclipsing their revenue from tuition” (pg. 33) [1].
  • St. Jude Graduate School of Biomedical Sciences
    • Runs BSL-3 labs
  • Galveston University
    • Runs BSL-4 labs
  • Boston University
    • Runs BSL-4 labs
  • UC Davis
    • Researchers emailed by Peter Daszak to hide viral sequences of coronaviruses
  • University of North Carolina, Chapel Hill
    • Ralph Baric
  • Stanford
    • Zeng Lei-Ping publications on GOF; post-doctoral at Stanford. An author of the two publications involving the use of HeLa cells that violated the White House moratorium on GOF research [120-121].
    • Steven Block -CIA-JASON that made a statement regarding ethnic-specificity of bioweapons
  • Emory University
    • Chinglai Yang, received millions in funding from NIAID
    • Hualan Chen
      • Received training in viral manipulation at US Centers for Disease Control (CDC) in Atlanta
        • Created hybridized “chimeric” virus that made the deadly bird flu transmissible to humans -from the 1918 pandemic flu virus and the H5N1 avian flu virus [1].
    • A university half a mile from CDC’s headquarters in Atlanta where Emory professor Walter Orenstein presided over the “Simpsonwood Conference” to “protect HHS’s institutional reputation.”
• USAID/CIA
  • “My uncle, President John F. Kennedy, created the USAID in November 1961 to administer humanitarian assistance and to promote democracy and economic development worldwide. Prior to the Kennedy administration, the [U.S. Department of State] distributed foreign aid as an adjunct Cold War foreign policy -US foreign assistance that tended to flow to military and civilian dictatorships with anti-communist bona fides. … Following JFK’s murder, military and corporate interests within President Lyndon’s administration co-opted USAID into working for the CIA.” (pg. 215)
    • “The [U.S. Department of State] funds USAID’s $63 billion annual budget ” (pg. 216) [1].
  • In Chapter 36, Robert F. Kennedy Jr. summarizes their lengthy history of international activities, such as election rigging, dating back to the 1960s [1], including….
    • 2009- “PREDICT” program launch and implemented by USAID’s Emerging Pandemic Threats (EPT)
    • 2009-2019- USSAID’s partnership with EcoHealth Alliance and PREDICT (UC-Davis Veterinary School)
    • 2014- Ukraine; CIA and U.S. Department of State involvement in coup of Ukraine’s government and replacing it with a pro-Western regime
    • 2020- on April 28, Peter Daszak emails EcoHealth, USAID, PREDICT, and UC-Davis to hide viral sequences of coronaviruses they had discovered in China and stored in the Wuhan lab
• Monetary
  • Costs of the Covid-19 “Countermeasures”
    • Working class lost $3.7 trillion
    • World billionaire’s made $3.9 trillion
    • Harvard economists estimate the cost of the COVID countermeasures at $16 trillion
  • “Countermeasures” profiteers
    • Bill Gates (+$33 billion)
    • Mark Zuckerberg (+$77.6 billion)
    • Sergey Brin (+$62 billion)
    • Larry Ellison (+$53.7 billion)
    • Mike Bloomberg (+$15 billion)
    • Jeremy Farrar (from £28,000 to £512,000)
    • Anthony Fauci (from $7.5 million $12.6 million)
  • Robert F. Kennedy Jr. criticizes U.S. Government virologists that benefit in their job security, power, prestige, influence, and status, quoting Dr. Francis Boyle’s term “Death Scientists” to regard virology’s GOF researchers.
    • Pending research question for the current Secretary of HHS: How has U.S. Government funded GOF research resulted in inequality between U.S. Government-employees and People of the United States of America?
• Operation Paperclip(s)
  • 1945- Japan: “Operation Paperclip of the East”
    • Unit 731 researchers conducting unethical experimentation given “immunity” by U.S. Government and recruited
  • 1945- Germany: “Operation Paperclip [of the West]”
    • 1,600 Germans, including at least 600 Nazis, also given immunity by U.S. Government and recruited
      • De-classifed CIA monograph: “Priority was accorded to atomic energy, biological warfare, chemical warfare, electronic warfare, guided missiles, aircraft, undersea warfare and medicine” (pg. 39) [1].
  • CIA
    • “Paperclip didn’t really take off until the CIA took control in 1947, immediately after Congress created the spy agency from the ashes of the disbanded OSS. Bioweapons research and development were therefore baked into the CIA’s DNA from the agency’s inception.” (pg. 39)
• World Health Organization
  • The current Secretary of HHS regards them as complicit in China’s cover up regarding the lab “leak.”
    • Jump to January 2025- President Donald Trump signed an executive order to withdraw from the WHO.
      • Jump to June 2025- I publish that the WHO may be covering up the Autism-Valproate link indicated on FDA package inserts, as they warn against pregnancy exposure due to developmental outcomes [154].
        • Jump to July 2026- I publish that the WHO recommends against genotoxicity safety tests for vaccines without scientific support for the genetic-safety of vaccines [155].
  • Attempted to declare another worldwide pandemic for monkeypox, which only had 130 deaths worldwide [1].
• Wuhan Institute of Virology
  • Major gain-of-function research site
  • Origin of the lab “leak”
  • Shi Zhengli stated there was going to be a “leak” before the “leak” happened
    • The “leak” happened after vaccine-manufacturer Moderna obtained an mRNA-vaccine patent from U.S. Government.
  • Heavily funded by U.S. Government
• Genetics
  • 1988- CIA-JASON Steven Block states biologal weapons can be created to have ethnic-specificity.
  • 2015- Chinese military manual is published that discusses how GOF research can be used for creating genetic [biological] weapons.
  • 2014- William Thompson: “I regret that my coauthors and I omitted statistically significant information in our 2004 article published in the journal Pediatrics. The omitted data suggested that African American males who received the MMR vaccine before age 36 months were at increased risk for autism. Decisions were made regarding which findings to report after the data were collected, and I believe that the final study protocol was not followed.” [3]
    • My pending research questions for the current Secretary of HHS: Can vaccines have ethnic-specific effects? Can Non-Clinical Toxicology safety studies be designed to evaluate ethnic-specificity? What are the research implications of ethnic-specificity of vaccines for single, multiple, and cumulative doses of vaccines as concerns genotoxicity/carcinogenicity?
• HeLa cells from Henrietta Lacks
  • An “immortal” cell line derived from the cancerous cervix of Henrietta Lacks, a black woman who worked on tobacco farms in Clover, Virginia -the same tobacco farms her slave ancestors had worked [135].
    • Elsie Lacks, her daughter, by 2026 standards might have been diagnosed with autism. She couldn’t speak and was institutionalized; but her medical records were lost due to being damaged. The official diagnosis given to her at the time was “idiocy,” a term no longer used in recent years [135].
    • Samples from Henrietta’s cervix were taken without consent [135] and were used in many lines of research, resulting in over 110,000 publications [122], including their use for polio, cancer, HIV, and tuberculosis research.
      • The NIH website page titled “Significant Research Advances Enabled by HeLa Cells” omits their use in bioweapons/GOF research [122].
    • Rebecca Skloot specifically discussed unethical experiments conducted by virologist Chester Southam in the 1950s involving the direct injection of HeLa cells into people without their knowledge much less their consent, such as the prisoners that volunteered to have HeLa cells injected into their forearms and developed tumors, and the refusal by 3 Jewish doctors who resigned from the Jewish Chronic Disease Hospital in Brooklyn, New York because they refused to carry out such experiments without informed consent, knowing by then the Nuremburg Trials and the unethical experiments conducted by Nazi’s upon Jewish prisoners [135].
      • New York State Attorney General Louis Lefkowitz: “Every human being has an unalienable right to determine what shall be done with his own body. These patients then had a right to know…the contents of the syringe: and if this knowledge was to cause fear and anxiety or make them frightened, they had a right to be fearful and frightened and thus say NO to the experiment.” [135]
        • A pending research question for the current Secretary of HHS: What implications does Robert F. Kennedy Jr. have regarding thus-called “Vaccine Hesitancy Research” funded by U.S. Government for researchers that do not know the contents of a vaccine syringe?
        • A pending research question for the current Secretary of HHS: What implications does Robert F. Kennedy Jr. have regarding informed consent for patients that do not know the contents of a vaccine syringe?
    • Unjust Enrichment implications: In 2023, Henrietta’s family won a legal battle on the basis of “Unjust Enrichment/Enriched by Misconduct” against Thermo Fisher Scientific due to the actions of John Hopkins Hospital which took her cells without her knowledge or informed consent [142-143].
      • “In the Lacks case, the family’s lawyers argued that doctors’ failure to ask her permission to use her cancer cells reflected deep-seated racism then pervasive in human research. “The racial inequity which was so eloquently argued in the complaint … really I think carried the day,” [142]
        • “…because it made the conscious choice to profit from the assault of Henrietta Lacks, Thermo Fisher Scientific’s ill-gotten gains rightfully belong to Ms. Lacks’ Estate” [143].
        • “Too often, the history of medical experimentation in the United States has been the history of medical racism” [143].
      • “Under settled law, as articulated in the Third Restatement of Restitution “a defendant who is enriched by misconduct and who acts [] with knowledge of the underlying wrong to the claimant” is a conscious wrongdoer liable for its profits “[143].
        • A pending research question for the current Secretary of HHS: What are the new implications for the “Unjust Enrichment/Enriched by Misconduct” of individuals -whether employed by U.S. Government or not- that were enriched the most from Covid “countermeasures” misconduct (e.g., 1st Amendment violations via the Appeal to Authority/Unity of “scientific consensus” to censor questions/statements against lab-leak hypotheses or treatments for Covid, stating the Pfizer vaccine prevented transmission when it did not, research suppression as in the case of the Xiao’s publication criticizing zoonotic origins, etc. [1]) from a pandemic derived from GOF-research that involved the use of HeLa cells [120-121]?
          • Some of the major Covid “Countermeasures” profiteers mentioned by the current Secretary of HHS Robert F. Kennedy Jr. [1].
            • Bill Gates (+$33 billion)
            • Mark Zuckerberg (+$77.6 billion)
            • Sergey Brin (+$62 billion)
            • Larry Ellison (+$53.7 billion)
            • Mike Bloomberg (+$15 billion)
            • Jeremy Farrar (from £28,000 to £512,000)
            • Anthony Fauci (from $7.5 million $12.6 million)
        • A pending research question for the current Secretary of HHS: What are the new implications for “Unjust Enrichment/Enriched by Misconduct” of U.S. Government-employees that he criticizes in Chapter 39 -as well as throughout his entire publication such as the funding of GOF-research [1]- to maintain “job security” yet drives inequality between U.S. Government and People of the United States of America, per his monetary criticisms of those who profited from the Covid “countermeasures” that cost the working class lost $3.7 trillion as a consequence?
          • “In 2001, someone within the US biological weapon program released anthrax, resulting in $5.9 trillion expenditures and passage of the Patriot Act” (pg. 256) [1].
          • “For every one of them, any release of a pandemic superbug is likely to increase their job security, their power, prestige, influence, and status” (pg. 256) [1].
        • A pending research question for the current Secretary of HHS: What are the implications regarding “Unjust Enrichment/Enriched by Misconduct” on the use of HeLa cells for GOF-research by U.S. Government-employees and/or U.S. Government funded researchers (e.g., Anthony Fauci, Peter Daszak, etc.) [1]?
        • A pending research question for the current Secretary of HHS: What are the implications regarding “Unjust Enrichment/Enriched by Misconduct” when U.S. Government employees profit from vaccine investments, or non-U.S. Government employees profit from vaccine investments as per his criticisms of Bill Gates, yet these profits are the direct consequence of U.S. Government-employee approval of vaccines that result in the outcomes the current Secretary of HHS reviews/summarizes in his own publications [1-2]?
    • I was assigned to read the book “The Immortal Life of Henrietta Lacks” as part of a California State University San Marcos (CSUSM) initiative to educate students on informed consent [139].
      • In March of 2012, students at CSUSM such as myself and other students from San Diego county universities attended a Q & A with the son of Henrietta Lacks, Sonny Lacks [139].
  • The most recent FDA Guidance for Industry document on the use of cell subtrates was published in 2010 [138]. The document does not, in large terms, discuss HeLa cells as the term can only be found once, but rather discusses avoiding tumorigenicity via oncogenicity tests.
    • A 2024 publication on the FDA website states the FDA is interested in using cell lines established from human tumors (they do not specify HeLa cells) in vaccine cultures again despite their previous experience that the use of them can lead to growth of tumors [141]. This is likely a covert reference to previous unethical experiments conducted with the injection of HeLa cells into prisoners or other research “participants” not properly informed of the risks [135].
      • “Our laboratory is developing new approaches, using rodent models as well as in vitro studies, to investigate whether the use of tumorigenic cells or cells derived from human tumors for vaccine production poses safety concerns to the recipients of those vaccines” [141].
      • “The regulations, in 21 CFR 610.13, state in part that “Products shall be free of extraneous material except that which is unavoidable in the manufacturing process described in the approved biologics license application.” In 21 CFR 600.3(r), purity is defined as the “relative freedom from extraneous matter in the finished product, whether or not harmful to the recipient or deleterious to the product.” (pg. 3) [138]
        • A pending research question for the current Secretary of HHS: Provided the 2024 publication clearly states the FDA is already researching the use of tumorigenic cells, most likely HeLa cells, for vaccine production [141], how can the FDA/CDC/NIH market vaccines as ‘safe’ while simultaneously stating in the FDA’s Guidance for Industry document for cell substrates for the development of viral vaccines that the “purity” of the vaccine is defined as only “relative freedom from extraneous matter in the finished product, whether or not harmful to the recipient or deleterious to the product”? [138, 141]?
        • In other words, the FDA’s own Guidance for Industry document does not guarantee that HeLa cells -or other cells “immortalized” by other processes such as with viral oncogenes [138]- won’t be injected into people by the very definition of “purity” as only “relative freedom from extraneous matter” [138].
          • “…immortalization of primary cells with viral oncogenes to generate a complementing cell line for production of defective viruses or viral vectors will inevitably change the phenotype of the cell. Such manipulations might induce the expression of latent or endogenous viruses, and/or might cause the cells to become tumorigenic.” (pg. 12) [138].
    • “Oncogenicity testing (see Section V. Glossary) is designed to assure that agents that could immortalize cells and endow them with the capacity to form tumors are not present in a cell substrate. If your vaccine is manufactured in a cell substrate that was derived from a tumor, or that has a tumorigenic phenotype through an unknown mechanism, it might carry a higher theoretical risk of containing oncogenic substances” [138].
      • “TUMORIGENICITY: Tumorigenicity is the process by which immortalized cells form tumors when inoculated into animals (see Tumorigenic). Tumorigenicity is distinct from Oncogenicity (See Oncogenicity)” [138]
        • “ONCOGENICITY: The property of certain biological agents (e.g., viruses) or materials (e.g., nucleic acids) that are capable of immortalizing cells and endowing them with the capacity to form tumors. Oncogenicity is distinct from tumorigenicity (See Tumorigenicity)” [138]
      • A pending research question for the current Secretary of HHS: What implications does Robert F. Kennedy Jr. have when the FDA published a Guidance for Industry document warning to use oncogenicity testing to ensure that vaccine manufacturing that utilized a cell substrate that was derived from a tumor (e.g., HeLa cells) is free of [viral] agents that could endow cells with the capacity to form tumors [138]?
  • Robert F. Kennedy Jr. incorrectly wrote in Chapter 46 that HeLa cells are human fetus cells.
    • New implication: HeLa cells, stolen from a poor black woman’s cancerous cervix in 1951 without her knowledge much less her informed consent, a woman descendant of slaves and who worked on the same tobacco farms her ancestors worked [135], are used in bioweapons/GOF research funded by U.S. Government [1, 120-121].
      • 1965- Mouse-HeLa hybrid cells first created from somatic cell fusion. Somatic cell fusion via viral infection can create hybrids via fusing cells of different species [135].
      • 1966- Stanley Gartler announces worldwide contamination of cell cultures by HeLa cells [135]
        • “The debate even ensnared Jonas Salk, MD, who stated at a conference in October 1978 that he had injected study subjects, enrolled in a vaccine trial, with HeLa cells that had contaminated his cultures; however, any mention of HeLa failed to find its way into his published remarks regarding the “ ‘theoretical’ possibility of transmitting a neoplasia-inducing factor” [137].
      • HeLa cells used in ACE and ACE2 receptor research
        • “In contrast, 293T cells expressing ACE2 did not form syncytia with cells expressing gp160 (top right), but formed many large syncytia with cells expressing S protein (bottom right). 293T cells expressing S protein also efficiently formed syncytia with ACE2- but not mock-transfected HeLa cells (not shown)” [144].
          • Novel Implication- This is a 2003 publication indicating that at least as early as 2003 HeLa cells were linked to bat coronavirus research. This does not mean HeLa cells may not have been used for other bioweapons research dating much earlier, as the 1945-year of the Operation Paperclip(s) were within the same decade as when HeLa cells were first taken in 1951.
        • “To test whether ACE could mediate the entry of SARS-CoV as ACE2, we transduced cDNA of human ACE into NIH/3T3 cells or HeLa cells, the ACE expressing cells could neither be infected by HIV/SARS (Fig. 4 A) nor bind to soluble S protein (Fig. 4B). Our data indicated that the ACE could not function as a receptor for SARS-CoV and the impairment of immune system in SARS patients might be due to other unknown reasons.” [145]
      • 2004- S-HeLa and HeLa-F5 created
        • “For this purpose, we established S-expressing HeLa cells (S-HeLa) by transducing the S gene into HeLa cells. When the F5 cells were co-cultured with S- HeLa cells, many syncytiums could be observed (Fig. 2C). These results demonstrated that F5 cells expressed a functional receptor [the receptor discussed in the study is ACE2] required for HIV/SARS pseudovirus or SARS-CoV infection, which not only had a high binding affinity with the S protein but also was sufficient to mediate the entry of the virus” [146].
          • Implication: this may be the first study in which HeLa cells were modified to possess the ACE2 receptor.
      • HeLa-mACE2
        • Huh-7 cells were used in virus infection and S protein binding assays. Mouse ACE2 (mACE2) gene was transduced into HeLa or NIH/3T3 cells by retroviral vector pBabe-puro containing mouse ACE2 gene and selected in culture medium containing 5
          g/ml puromycin to establish the mACE2-expressing cell lines. The expression of mACE2 protein was confirmed in these stable cell lines HeLa-mACE2 and 3T3-mACE2 [147].
      • Ren, W., Qu, X., Li, W., Han, Z., Yu, M., Zhou, P., Zhang, S. Y., Wang, L. F., Deng, H., & Shi, Z. (2008). Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. (Citation 6 in Chapter 43 of The Wuhan Cover Up book), citation 148 in this publication.
        • HeLa-huACE2 (seems to be synonymous with HeLa-hACE2)
          • “Cell lines expressing huACE2 and palm civet (pcACE2) proteins were established in a previous study” [148].
        • HeLa-pcACE2 [pc = palm civet)]
          • “Cell lines expressing huACE2 and palm civet (pcACE2) proteins were established in a previous study” [148].
        • HeLa-RpACE2 [rp = horseshoe bat R. pearsonii]
          • “The bat ACE2 coding region was cloned into a retroviral vector, pBabe-pure, and then transduced into HeLa cells to generate stable cell lines expressing the bat ACE2 by following the same procedures described previously” [148].
        • Described by the current Secretary of HHS as a study that would identify the change required to enable the SARS-like viruses to infect humans [1].
      • Ge, X. Y., Li, J. L., Yang, X. L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., Zhang, Y. J., Luo, C. M., Tan, B., Wang, N., Zhu, Y., Crameri, G., Zhang, S. Y., Wang, L. F., Daszak, P., & Shi, Z. L. (2013). Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. (Citation 74 in Chapter 43 of The Wuhan Cover Up book), citation 149 in this publication.
        • HeLa-huACE2, HeLa-pcACE2, and HeLa-rpACE2 used in the study; although the terms Hela-hACE2, HeLa-cACE2, and HeLa-bACE2 will be seen instead.
        • Described by Robert F. Kennedy Jr. [1] as the study that Ralph Baric obtained from Shi Zhengli the SHC014 sequence for his later publication [151].
          • Menachery, V. D., Yount, B. L., Jr, Debbink, K., Agnihothram, S., Gralinski, L. E., Plante, J. A., Graham, R. L., Scobey, T., Ge, X. Y., Donaldson, E. F., Randell, S. H., Lanzavecchia, A., Marasco, W. A., Shi, Z. L., & Baric, R. S. (2015). A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. (Citation 68 in Chapter 43 of The Wuhan Cover Up book), citation 151 in this publication.
            • HeLa cells with ACE2 receptor utilized as part of the study
            • Regarded as the “smoking gun” publication tracing the Covid pandemic origins to gain-of-function research [1].
          • Yang, X. L., Hu, B., Wang, B., Wang, M. N., Zhang, Q., Zhang, W., Wu, L. J., Ge, X. Y., Zhang, Y. Z., Daszak, P., Wang, L. F., & Shi, Z. L. (2015). Isolation and Characterization of a Novel Bat Coronavirus Closely Related to the Direct Progenitor of Severe Acute Respiratory Syndrome Coronavirus.
            • Publication involving the use of HeLa-ACE2 to ascertain bat coronavirus infectivity [150].
      • Human transmission of the new bat coronaviruses, developed via GOF-research was tested on HeLa cells with the ACE2 receptor [121].
        • Regarded as proof that Wuhan’s U.S. Government funded GOF-researchers knew what mutations were needed to allow specific bat coronaviruses to bind to human ACE2 receptors (via HeLa cell and other tests).
      • New research question: What implications does the current Secretary of HHS have for the Lacks’ family regarding the use of HeLa cells for U.S. Government funded bioweapons/GOF research, where GOF/bioweapons researchers conducting such research -such as Stanford’s Zeng, L. P., “batwoman” Shi, Z. L., Daszak, P., and Ben Hu “Covid patient zero” [120-121]- have profited/benefitted from the use of Henrietta Lacks’ cells?
      • A pending question for the current Secretary of HHS: Does Robert F. Kennedy Jr. condone the use of HeLa cells for bioweapons/GOF research under “Permissible” GOF-research [10], as per his statement of support for such “lifesaving biomedical research” [9]?
      • In her book, Rebecca Skloot discusses the option that the Lacks family have to launch a lawsuit to discontinue research that uses HeLa cells due to the fact that they contains their family DNA because it’s now impossible to anonymize Henrietta’s cells [135]. Sonny said to Rebecca “I don’t want to cause problems for science” when discussing these matters, knowing HeLa cells are widely used in research [135]. Autism Librarian’s new pending research question for the ethics literatures: What are the ethical implications regarding the use of HeLa cells in bioweapons research for the Lacks’ family and their ability to make an informed decision regarding the continued use of HeLa cells in research if the Lacks family knew the use of HeLa cells in gain-of-function research contributed toward the Covid “pandemic” [1, 120-121], or that the CDC’s own Vaccine Safety Datalink reveals links between autism and vaccines [2]?
    • New implication: HeLa cells, regarded as a great contributor toward vaccine development [122], yet vaccine research is regarded by Robert F. Kennedy Jr. as bioweapons research dating back to Operation Paperclip’s recruitment of Nazis [1], and may have indirectly contributed toward the development of the MMR vaccine which CDC Scientist William Thompson declared via his attorney was negatively affecting African American boys with autism [3],
      • A pending question for the current Secretary of HHS: How does Robert F. Kennedy Jr. think the Lacks’ family would feel knowing that no vaccine has undergone mutagenic/carcinogenic safety tests in spite of Henrietta dying from cervical cancer [11-117, 124-127], he himself compiled vaccinated versus unvaccinated studies on the link between autism and vaccines [2], and that bioweapons research using HeLa cells contributed toward the Covid “pandemic” [1, 120-121]?
      • A pending question for the current Secretary of HHS: How does Robert F. Kennedy Jr. think the Lacks family would respond regarding the use of HeLa cells in vaccine research [122, 135, 141], knowing that CDC scientist William Thompson released a statement via his attorney that the MMR vaccine was adversely affecting African American boys [3]?
    • New Implication: Despite Rebecca Skloot’s publication in 2010 to highlight informed consent in research/medicine and the ethical implications of the continued use of HeLa cells in research [135], U.S. Government funded GOF research that involved the use of HeLa cells and contributed toward the Covid pandemic [1, 120-121, 135].
    • New Implication: A moratorium on gain-of-function research from the first African American President was violated/disregarded, was funded by U.S. Government’s NIAID/USAID both of which Robert F. Kennedy Jr. criticizes for bioweapons research linked through the CIA dating back to the 1945-Japanese and 1945-German Operation Paperclips involving Nazi’s being recruited for U.S. Government bioweapons research, and the GOF research involved the use of cells derived in 1951 from a poor African American woman without her knowledge/informed consent [1, 120-121, 135].
    • New implications for Informed Consent: HeLa cells, stolen from Henrietta without her knowledge much less her informed consent are used for vaccine research [122, 135] via cell culture research because poliovirus was replicating more efficiently in HeLa cells than in monkey testicle tissue [122, 135, 140], resulting in over 100 thousand publications [122] for the benefit/profit of researchers while Henrietta’s family had no idea her cells were taken for over 20 years [135] yet there is lack of informed consent regarding lack of Mutagenic/Carcinogenic safety tests for vaccines presently approved by the FDA [11-117], or polio vaccines containing live-strains used worldwide [124-127] despite published FDA guidelines for genotoxicity safety tests since 1996 [128] and despite lack of scientific support from the World Health Organization regarding the genetic-safety of vaccines [130-131]?
    • John Hopkins Hospital researcher George Gey utilized Henrietta’s cells for cell culture research [135-136].
      • The current Secretary of HHS discussed how John Hopkins University was one of the universities involved in bioweapons research and co-hosted Event 201 the pandemic simulation [1].
    • New implication: Ralph Baric’s reverse genetics technology descriptions in the study that contradicted Anthony Fauci’s claim that NIAID was not funding GOF research involved the use of HeLa cells [121].
    • New implication: Although HeLa cells are hailed as a contributor toward vaccine development by the NIH as in the case of the HPV vaccines [122], the current Secretary of HHS complied in Chapter 5 of his Vax-Unvax publication [2] vaccinated-unvaccinated health outcome studies on HPV vaccine associations: serious injuries, death, permanent disability, memory impairment, involuntary movement, dyscalculia, anti-brain protein antibodies in mice, anti-brain phospholipid antibodies in mice, celiac disease, and asthma [2].
      • Pending research question for the current Secretary of HHS: Henrietta died of cervical cancer and her cells were used to discover how the HPV virus can led to cervical cancer [122]. However, Henrietta’s family believes the HPV vaccines through the use of Henrietta’s cells have positively contributed to science despite Robert F. Kennedy Jr.’s criticisms in Chapter 5 on the pre-approval clinical trials as well as the adverse health outcomes of HPV vaccines [2]. What are the new ethical implications for the Lacks family’s consent to the continued use of HeLa cells which contains their family’s genetic information provided Robert F. Kennedy Jr.’s criticisms of Chapter 5 [2]?
    • New implication: Although HeLa cells are hailed as a contributor toward vaccine development by the NIH as in the case of the polio vaccines [122], the current Secretary of HHS cited a study in Chapter 4 of his Vax-Unvax publication that found an increased risk of Crohn’s disease and ulcerative colitis following polio vaccination [2].
      • Pending research question for the current Secretary of HHS: Henrietta’s cells contributed toward the development of the first polio vaccines [122]. What are the new ethical implications for the Lacks family’s consent to the continued use of HeLa cells which contains their family’s genetic information provided Robert F. Kennedy Jr.’s criticisms of Chapter 4 regarding polio vaccines [2]?
        • Pending research question for the current Secretary of HHS: Provided the entirety of Robert F. Kennedy Jr.’s publication on adverse health outcomes following vaccination [2], in the context of HeLa cells regarded by NIH as contributing toward vaccine development [122], what are the new ethical implications for the Lacks family’s consent to the continued use of HeLa cells which contains their family’s genetic information?
    • New implication: If HeLa cells are used in bioweapons research, and if HeLa cells are used in bioweapons research for the development of ethnic-specific bioweapons as per the current Secretary of HHS inclusion of CIA’s Jason Block’s statement and the Chinese military manual mentioning genetic bioweapons [1] (hereby called “Racist Bioweapons”), then the implication is that during the racist Jim Crow laws cells from a poor black woman descendant of slaves were taken without her consent from white doctors that would remove tissue samples from black women in the segregated wards for black people at John Hopkins hospital [135, 143] are used to research the development of Racist Bioweapons.
      • My pending research question for Robert F. Kennedy Jr. the current Secretary of HHS: Per his statement that “ensuring America remains the global leader in ethical, responsible, and lifesaving biomedical research” [9], research that he regards in this book as bioweapons research [1], does the current Secretary of HHS condone U.S. Government funding of research that utilizes HeLa cells for the development of Racist Bioweapons?
      • My pending research question for the ethics literatures: what are the ethical implications of the use of HeLa cells for research/development of Racist Bioweapons in the context of Henrietta herself being a victim of racist segregation in the ward at John Hopkins hospital [143], lack of informed consent for her cells being taken, and in the broad history of racism in the United States of America and unethical experiments on African Americans [137]?
• U.S. Government has funded Gain of Function research that…
  • 1. “The benefits of GOF, if any, have never been quantified and appear to be negligible.” [1]
  • 2. “The risks have never been quantified but appear to be monumental,” although I would propose that Chapter 27 offers a preliminary quantification pending further data on each of those events plus additional biolab incidents that remain undisclosed by U.S. Government to the People of the United States of America. [1]
    • Additionally, the Chapter 54 inclusion of the Harvard researchers’ calculation of the $17 trillion cost of the Covid “pandemic” countermeasures including $3.7 trillion lost by the working class can be regarded as a quantification.
  • 3. “The cataclysmic impacts of a pandemic, multiplied by the frequency of escape, makes such research intolerable and unacceptable to [People of the United States of America].” [1]
  • 4. The risks of zoonotic spillover have never been quantified and seem quite low. [1]

Please also see, if needed:

“The Wuhan Cover-Up”: Commentaries by Autism Librarian (Chs. 1-3)

“The Wuhan Cover-Up”: Commentaries by Autism Librarian (Chs. 4-6)

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 7-8

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 9-13

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 14-15

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 16-18

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 19-22

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 23-24

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 25-27

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 28-29

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 30-31

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Ch. 32

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Ch.- 33

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Ch.- 34-35

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 36-37

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Ch. 38

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Ch. 39

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Ch. 40 – Population Control and a Personal Statement

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 41-42

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 43-44

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 45-47

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Ch. 48

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 49-50

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 51-52

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 53-54

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 55-57

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 58-59

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 60-61 – Logical Fallacies

“The Wuhan Cover-Up”: Commentaries by Autism Librarian -Chs. 62-63 – And a New Policy on “Permissible” Gain-of-Function Research…?

References

1. Kennedy, R. F., Jr. (2023). The Wuhan cover-up: And the terrifying bioweapons arms race. Skyhorse Publishing.
2. Kennedy, R. F., Jr., & Hooker, B. (2023). Vax-unvax: Let the science speak. Skyhorse Publishing.
3. Thompson, W. W. (2014, August 27). Statement of William W. Thompson, Ph.D., regarding the 2004 article examining the possibility of a relationship between MMR vaccine and autism [Press release]. Morgan Verkamp, LLC. https://web.archive.org/web/20150221101545/http://www.morganverkamp.com/august-27-2014-press-release-statement-of-william-w-thompson-ph-d-regarding-the-2004-article-examining-the-possibility-of-a-relationship-between-mmr-vaccine-and-autism
4. U.S. Department of State, Bureau of Arms Control, Deterrence, and Stability. (2025). Adherence to and compliance with arms control, nonproliferation, and disarmament agreements and commitments. https://www.state.gov/wp-content/uploads/2025/04/2025-Arms-Control-Treaty-Compliance-Report_Final-Accessible.pdf
5. Executive Order No. 14,292. (2025, May 5). Improving the safety and security of biological research. The White House. https://www.whitehouse.gov/presidential-actions/2025/05/improving-the-safety-and-security-of-biological-research/
6. Office of the Director of National Intelligence. (2026, April 23). IC analysis: Concerns with CTR supported labs in Ukraine [Presentation slides]. https://www.dni.gov/files/BIOLAB_Slides.pdf
7. Institute of Medicine (US) Committee on Review of Priorities in the National Vaccine Plan. Priorities for the National Vaccine Plan. Washington (DC): National Academies Press (US); 2010. Appendix C, 1986 National Childhood Vaccine Injury Act (Public Law 99-660) Available from: https://www.ncbi.nlm.nih.gov/books/NBK220067/
8. National Security Council. (1974, December 10). National security study memorandum 200: Implications of worldwide population growth for U.S. security and overseas interests (NSSM 200). U.S. Agency for International Development. https://web.archive.org/web/20061011042246/http://pdf.usaid.gov/pdf_docs/PCAAB500.pdf
9. U.S. Department of Health and Human Services. (2026, July 28). Trump Administration releases new government-wide policy to end dangerous high-risk research [Press release]. https://www.hhs.gov/press-room/stopping-high-risk-life-sciences-research.html
10. White House Office of Science and Technology Policy. (2026, July 20). United States Government policy for stopping high-risk life sciences research. The White House. https://www.whitehouse.gov/wp-content/uploads/2026/07/USG-Policy-for-Stopping-High-Risk-Life-Sciences-Research_July-2026.pdf
11. U.S. Food and Drug Administration. (2019). Adenovirus type 4 and type 7 vaccine, live, oral: Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/80211/download?attachment
12. U.S. Food and Drug Administration. (2025). CYFENDUS (anthrax vaccine adsorbed, adjuvanted): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/189503/download?attachment
13. U.S. Food and Drug Administration. (2025). BIOTHRAX (anthrax vaccine adsorbed): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/71954/download?attachment
14. U.S. Food and Drug Administration. (n.d.). VIMKUNYA (chikungunya vaccine, recombinant): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/185477/download?attachment
15. U.S. Food and Drug Administration. (2024). VAXCHORA (cholera vaccine, live, oral): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/179631/download?attachment
16. U.S. Food and Drug Administration. (2025). MNEXSPIKE (COVID-19 vaccine, mRNA): 2025–2026 formula—Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/186738/download?attachment
17. U.S. Food and Drug Administration. (2025). NUVAXOVID (COVID-19 vaccine, adjuvanted): 2025–2026 formula—Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/186544/download?attachment
18. U.S. Food and Drug Administration. (2026). COMIRNATY (COVID-19 vaccine, mRNA): 2025–2026 formula—Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/151707/download?attachment
19. U.S. Food and Drug Administration. (2025). SPIKEVAX (COVID-19 vaccine, mRNA): 2025–2026 formula—Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/155675/download?attachment
20. U.S. Food and Drug Administration. (2023). DENGVAXIA (dengue tetravalent vaccine, live): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/124379/download?attachment
21. U.S. Food and Drug Administration. (2026). INFANRIX (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75157/download?attachment
22. U.S. Food and Drug Administration. (n.d.). DAPTACEL (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/74035/download?attachment
23. U.S. Food and Drug Administration. (2026). PEDIARIX (diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B [recombinant] and inactivated poliovirus vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/79830/download?attachment
24. U.S. Food and Drug Administration. (2026). KINRIX (diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/80128/download?attachment
25. U.S. Food and Drug Administration. (2026). Quadracel (diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/146047/download?attachment
26. U.S. Food and Drug Administration. (2026). VAXELIS (diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus b conjugate and hepatitis B vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/119465/download?attachment
27. U.S. Food and Drug Administration. (2025). Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus b conjugate vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/146048/download?attachment
28. U.S. Food and Drug Administration. (2026). ERVEBO (Ebola Zaire vaccine, live): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/133748/download?attachment
29. U.S. Food and Drug Administration. (2010). Liquid PedvaxHIB (Haemophilus b conjugate vaccine [meningococcal protein conjugate]): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/80438/download?attachment
30. U.S. Food and Drug Administration. (2022). ActHIB (Haemophilus b conjugate vaccine [tetanus toxoid conjugate]): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/74395/download?attachment
31. U.S. Food and Drug Administration. (2025). HIBERIX (Haemophilus b conjugate vaccine [tetanus toxoid conjugate]): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/77017/download?attachment
32. U.S. Food and Drug Administration. (2026). HAVRIX (hepatitis A vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/119388/download?attachment
33. U.S. Food and Drug Administration. (n.d.). VAQTA (hepatitis A vaccine, inactivated): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/74519/download?attachment
34. U.S. Food and Drug Administration. (2023). TWINRIX (hepatitis A & hepatitis B [recombinant] vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/119351/download?attachment
35. U.S. Food and Drug Administration. (2018). RECOMBIVAX HB (hepatitis B vaccine, recombinant): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/74274/download?attachment
36. U.S. Food and Drug Administration. (n.d.). PREHEVBRIO (hepatitis B vaccine [recombinant]): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/154561/download?attachment
37. U.S. Food and Drug Administration. (2026). ENGERIX-B (hepatitis B vaccine [recombinant]): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/119403/download?attachment
38. U.S. Food and Drug Administration. (2024). HEPLISAV-B (hepatitis B vaccine [recombinant], adjuvanted): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/108745/download?attachment
39. U.S. Food and Drug Administration. (n.d.). GARDASIL (human papillomavirus quadrivalent [types 6, 11, 16, and 18] vaccine, recombinant): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/186364/download?attachment
40. U.S. Food and Drug Administration. (2025). GARDASIL 9 (human papillomavirus 9-valent vaccine, recombinant): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/90064/download?attachment
41. U.S. Food and Drug Administration. (2009). CERVARIX (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/78013/download?attachment
42. U.S. Food and Drug Administration. (2009). Influenza A (H1N1) 2009 monovalent vaccine: Package insert. U.S. Department of Health and Human Services. https://www.fda.gov/media/77464/download?attachment
43. U.S. Food and Drug Administration. (2009). Influenza A (H1N1) 2009 monovalent vaccine live, intranasal: Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/77482/download?attachment
44. U.S. Food and Drug Administration. (2010). Influenza A (H1N1) 2009 monovalent vaccine: Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/77835/download?attachment
45. U.S. Food and Drug Administration. (2009). Influenza A (H1N1) 2009 monovalent vaccine: Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/77422/download?attachment
46. U.S. Food and Drug Administration. (2009). Influenza A (H1N1) 2009 monovalent vaccine: Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/77474/download?attachment
47. U.S. Food and Drug Administration. (2024). AREPANRIX (influenza A [H5N1] virus vaccine, adjuvanted): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/182872/download?attachment
48. U.S. Food and Drug Administration. (2007). Influenza virus vaccine, H5N1: Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/74534/download?attachment
49. U.S. Food and Drug Administration. (2023). AUDENZ (influenza A [H5N1] monovalent vaccine, adjuvanted): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/135020/download?attachment
50. U.S. Food and Drug Administration. (2023). FLUAD QUADRIVALENT (influenza vaccine, adjuvanted): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/135432/download?attachment
51. U.S. Food and Drug Administration. (2026). FLUAD (influenza vaccine, adjuvanted): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/179766/download?attachment
52. U.S. Food and Drug Administration. (2026). AFLURIA QUADRIVALENT (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/117022/download?attachment
53. U.S. Food and Drug Administration. (2026). FLUCELVAX QUADRIVALENT (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/115862/download?attachment
54. U.S. Food and Drug Administration. (2023). FLULAVAL QUADRIVALENT (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/115785/download?attachment
55. U.S. Food and Drug Administration. (2026). MFLUSIVA (influenza vaccine, mRNA): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/194120/download?attachment
56. U.S. Food and Drug Administration. (2026). AFLURIA (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/81559/download?attachment
57. U.S. Food and Drug Administration. (2026). FLULAVAL (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/191667/download?attachment
58. U.S. Food and Drug Administration. (2026). FluMist (influenza vaccine live, intranasal): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/180697/download?attachment
59. U.S. Food and Drug Administration. (2026). FLUARIX (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/84804/download?attachment
60. U.S. Food and Drug Administration. (2017). FLUVIRIN (influenza virus vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75156/download?attachment
61. U.S. Food and Drug Administration. (2020). AGRIFLU (influenza virus vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/134739/download?attachment
62. U.S. Food and Drug Administration. (2026). Fluzone (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/170019/download?attachment
63. U.S. Food and Drug Administration. (2026). FLUCELVAX (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/85322/download
64. U.S. Food and Drug Administration. (2026). Flublok (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/179778/download?attachment
65. U.S. Food and Drug Administration. (2023). Flublok Quadrivalent (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/123144/download
66. U.S. Food and Drug Administration. (2023). FluMist Quadrivalent (influenza vaccine live, intranasal): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/160349/download?attachment
67. U.S. Food and Drug Administration. (2023). FLUARIX QUADRIVALENT (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/79278/download?attachment
68. U.S. Food and Drug Administration. (2026). Fluzone (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/170019/download?attachment
69. U.S. Food and Drug Administration. (2026). Fluzone High-Dose (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/139731/download?attachment
70. U.S. Food and Drug Administration. (2026). Fluzone High-Dose Southern Hemisphere (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/165357/download?attachment
71. U.S. Food and Drug Administration. (2026). Fluzone Southern Hemisphere (influenza vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/120054/download?attachment
72. U.S. Food and Drug Administration. (n.d.). Fluzone Quadrivalent (influenza vaccine): Prescribing information (2025–2026 formula). U.S. Department of Health and Human Services. https://www.fda.gov/media/119856/download?attachment
73. U.S. Food and Drug Administration. (2016). Fluzone Intradermal Quadrivalent (influenza vaccine): Prescribing information, 2016–2017 formula. https://www.fda.gov/media/90251/download?attachment
74. U.S. Food and Drug Administration. (2018). IXIARO (Japanese encephalitis vaccine, inactivated, adsorbed): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75777/download?attachment
75. U.S. Food and Drug Administration. (2026). PRIORIX (measles, mumps, and rubella vaccine, live): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/189623/download?attachment
76. U.S. Food and Drug Administration. (2025). M-M-R II (measles, mumps, and rubella virus vaccine live): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75191/download?attachment
77. U.S. Food and Drug Administration. (2025). ProQuad (measles, mumps, rubella and varicella virus vaccine live): Prescribing information—Refrigerator-stable formulation. U.S. Department of Health and Human Services. https://www.fda.gov/media/75195/download?attachment
78. U.S. Food and Drug Administration. (2025). ProQuad (measles, mumps, rubella and varicella virus vaccine live): Prescribing information—Frozen formulation, recombinant human albumin (RHA). U.S. Department of Health and Human Services. https://www.fda.gov/media/119880/download?attachment
79. U.S. Food and Drug Administration. (n.d.). ProQuad (measles, mumps, rubella and varicella virus vaccine live): Prescribing information—Frozen formulation, human serum albumin (HSA). U.S. Department of Health and Human Services. https://www.fda.gov/media/75203/download?attachment
80. U.S. Food and Drug Administration. (2024). ProQuad (measles, mumps, rubella and varicella virus vaccine live): Prescribing information—Frozen formulation. U.S. Department of Health and Human Services. https://www.fda.gov/media/147563/download?attachment
81. U.S. Food and Drug Administration. (2024). PENBRAYA (meningococcal groups A, B, C, W, and Y vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/173223/download?attachment
82. U.S. Food and Drug Administration. (2025). PENMENVY (meningococcal groups A, B, C, W, and Y vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/185479/download?attachment
83. U.S. Food and Drug Administration. (n.d.). MENVEO (meningococcal groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/78514/download?attachment
84. U.S. Food and Drug Administration. (2018). Menactra (meningococcal [groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75619/download?attachment
85. U.S. Food and Drug Administration. (2024). BEXSERO (meningococcal group B vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/90996/download?attachment
86. U.S. Food and Drug Administration. (2024). Trumenba (meningococcal group B vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/89936/download?attachment
87. U.S. Food and Drug Administration. (2025). MenQuadfi (meningococcal [groups A, C, Y, W] conjugate vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/137306/download?attachment
88. U.S. Food and Drug Administration. (2026). VAXNEUVANCE (pneumococcal 15-valent conjugate vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/150819/download?attachment
89. U.S. Food and Drug Administration. (n.d.). PREVNAR 20 (pneumococcal 20-valent conjugate vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/149987/download?attachment
90. U.S. Food and Drug Administration. (2026). CAPVAXIVE (pneumococcal 21-valent conjugate vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/179426/download?attachment
91. U.S. Food and Drug Administration. (2022). IPOL (poliovirus vaccine inactivated): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75695/download?attachment
92. U.S. Food and Drug Administration. (2025). IMOVAX RABIES (rabies vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75709/download?attachment
93. U.S. Food and Drug Administration. (2019). RabAvert (rabies vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/83874/download?attachment
94. U.S. Food and Drug Administration. (2026). ROTARIX (rotavirus vaccine, live, oral): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/163009/download?attachment
95. U.S. Food and Drug Administration. (2026). RotaTeq (rotavirus vaccine, live, oral, pentavalent): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75718/download?attachment
96. U.S. Food and Drug Administration. (2026). MRESVIA (respiratory syncytial virus vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/179005/download?attachment
97. U.S. Food and Drug Administration. (2025). ABRYSVO (respiratory syncytial virus vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/168889/download?attachment
98. U.S. Food and Drug Administration. (2026). AREXVY (respiratory syncytial virus vaccine, adjuvanted): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/167805/download?attachment
99. U.S. Food and Drug Administration. (n.d.). JYNNEOS (smallpox and mpox vaccine, live, non-replicating): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/131078/download?attachment
100. U.S. Food and Drug Administration. (n.d.). JYNNEOS (smallpox and mpox vaccine, live, non-replicating): Prescribing information—Frozen formulation. U.S. Department of Health and Human Services. https://www.fda.gov/media/186359/download?attachment
101. U.S. Food and Drug Administration. (2024). ACAM2000 (smallpox and mpox [vaccinia] vaccine, live): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75792/download?attachment
102. U.S. Food and Drug Administration. (2018). TDVAX (tetanus and diphtheria toxoids adsorbed): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/76430/download?attachment
103. U.S. Food and Drug Administration. (2018). TDVAX (tetanus and diphtheria toxoids adsorbed): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/117947/download?attachment
104. U.S. Food and Drug Administration. (n.d.). TENIVAC (tetanus and diphtheria toxoids adsorbed): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/76610/download?attachment
105. U.S. Food and Drug Administration. (2026). Adacel (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/119862/download?attachment
106. U.S. Food and Drug Administration. (2026). BOOSTRIX (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/124002/download?attachment
107. U.S. Food and Drug Administration. (n.d.). TICOVAC (tick-borne encephalitis vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/151502/download?attachment
108. U.S. Food and Drug Administration. (2013). VIVOTIF (typhoid vaccine live oral Ty21a): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75988/download?attachment
109. U.S. Food and Drug Administration. (2020). Typhim Vi (typhoid Vi polysaccharide vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/75993/download?attachment
110. U.S. Food and Drug Administration. (2025). YF-VAX (yellow fever vaccine): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/76015/download?attachment
111. U.S. Food and Drug Administration. (2019). ZOSTAVAX (zoster vaccine live): Prescribing information—Frozen formulation. U.S. Department of Health and Human Services. https://www.fda.gov/media/119879/download?attachment
112. U.S. Food and Drug Administration. (2018). ZOSTAVAX (zoster vaccine live): Prescribing information—Refrigerated formulation. U.S. Department of Health and Human Services. https://www.fda.gov/media/82524/download?attachment
113. U.S. Food and Drug Administration. (2026). SHINGRIX (zoster vaccine recombinant, adjuvanted): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/108597/download?attachment
114. U.S. Food and Drug Administration. (2023). VARIVAX (varicella virus vaccine live): Prescribing information—Refrigerator formulation. U.S. Department of Health and Human Services. https://www.fda.gov/media/76000/download?attachment
115. U.S. Food and Drug Administration. (2023). VARIVAX (varicella virus vaccine live): Prescribing information—Frozen formulation. U.S. Department of Health and Human Services. https://www.fda.gov/media/76008/download?attachment
116. U.S. Food and Drug Administration. (2021). PNEUMOVAX 23 (pneumococcal vaccine polyvalent): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/80547/download?attachment
117. U.S. Food and Drug Administration. (n.d.). BCG vaccine (TICE strain): Prescribing information. U.S. Department of Health and Human Services. https://www.fda.gov/media/78331/download?attachment
118. U.S. Department of Health and Human Services. (2026, July 29). Joint statement on strengthening vaccine safety, accountability, and American leadership in global health. https://www.hhs.gov/press-room/joint-statement-strengthening-vaccine-safety-accountability-american-leadership-global-health.html
119. Public Readiness and Emergency Preparedness Act, Pub. L. No. 109-148, 119 Stat. 2818 (2005). https://www.govinfo.gov/content/pkg/STATUTE-119/pdf/STATUTE-119-Pg2680.pdf#page=51
120. Zeng, L. P., Gao, Y. T., Ge, X. Y., Zhang, Q., Peng, C., Yang, X. L., Tan, B., Chen, J., Chmura, A. A., Daszak, P., & Shi, Z. L. (2016). Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response. Journal of virology, 90(14), 6573–6582. https://doi.org/10.1128/JVI.03079-15
121. Hu, B., Zeng, L. P., Yang, X. L., Ge, X. Y., Zhang, W., Li, B., Xie, J. Z., Shen, X. R., Zhang, Y. Z., Wang, N., Luo, D. S., Zheng, X. S., Wang, M. N., Daszak, P., Wang, L. F., Cui, J., & Shi, Z. L. (2017). Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS pathogens, 13(11), e1006698. https://doi.org/10.1371/journal.ppat.1006698
122. National Institutes of Health, Office of Science Policy. (2025). Significant research advances enabled by HeLa cells. https://osp.od.nih.gov/hela-cells/significant-research-advances-enabled-by-hela-cells/
123. Centers for Disease Control and Prevention. (2024, July 31). Possible side effects from vaccines. https://www.cdc.gov/vaccines/basics/possible-side-effects.html
124. World Health Organization. (2015). Polio Sabin One and Three (oral): Package insert. GlaxoSmithKline Biologicals. https://web.archive.org/web/20121004000821/https://www.who.int/immunization_standards/vaccine_quality/OPV_bivalent_GSK_WHO_package_insert_text_english.pdf
125. Panacea Biotec Ltd. (2018). Bivalent poliomyelitis vaccine type 1 & type 3, live (oral) (bOPV): Package insert (PMPIS05703). https://media.panaceabiotec.com/documents/2019/7/24/bOPV%28PTB%29-Package-Insert_.pdf
126. Bharat Biotech International Limited. (2013). BIOPOLIO: Trivalent poliomyelitis vaccine type 1, type 2 and type 3, live (oral): Summary of product characteristics. Central Drugs Standard Control Organisation. https://www.cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadSmPC/1bhrat.pdf
127. Bio Farma. (2008). Monovalent oral poliomyelitis vaccine type 1 (mOPV1): Package insert. World Health Organization. https://extranet.who.int/prequal/sites/default/files/vwa_vaccine/pq_190_mOPV1_20dose_BioFarma_PI.pdf
128. U.S. Food and Drug Administration. (1996). Specific aspects of regulatory genotoxicity tests for pharmaceuticals. U.S. Department of Health and Human Services. https://www.fda.gov/media/71959/download
129. U.S. Food and Drug Administration. (2006). Nonclinical safety evaluation of drug or biologic combinations: Guidance for industry. U.S. Department of Health and Human Services. https://www.fda.gov/media/119657/download
130. World Health Organization. (2005). WHO guidelines on nonclinical evaluation of vaccines (WHO Technical Report Series No. 927, Annex 1). https://cdn.who.int/media/docs/default-source/biologicals/vaccine-standardization/annex-1nonclinical.p31-63.pdf?sfvrsn=e87c28d8_3&download=true
131. World Health Organization. (2014). Guidelines on the nonclinical evaluation of vaccine adjuvants and adjuvanted vaccines. (WHO Technical Report Series No. 987, Annex 2). https://cdn.who.int/media/docs/default-source/biologicals/vaccine-standardization/trs_987_annex2.pdf?sfvrsn=ea91caca_3&download=true
132. Albrecht T, Fons M, Boldogh I, et al. Effects on Cells. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 44. Available from: https://www.ncbi.nlm.nih.gov/books/NBK7979/
133. Baron S, Fons M, Albrecht T. Viral Pathogenesis. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 45. Available from: https://www.ncbi.nlm.nih.gov/books/NBK8149/
134. Dianzani F, Baron S. Nonspecific Defenses. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 49. Available from: https://www.ncbi.nlm.nih.gov/books/NBK8348/
135. Skloot, R. (2010). The immortal life of Henrietta Lacks. Crown Publishers.
136. Lucey, B. P., Nelson-Rees, W. A., & Hutchins, G. M. (2009). Henrietta Lacks, HeLa cells, and cell culture contamination. Archives of pathology & laboratory medicine, 133(9), 1463–1467. https://doi.org/10.5858/133.9.1463
137. Baptiste, D. L., Caviness-Ashe, N., Josiah, N., Commodore-Mensah, Y., Arscott, J., Wilson, P. R., & Starks, S. (2022). Henrietta Lacks and America’s dark history of research involving African Americans. Nursing open, 9(5), 2236–2238. https://doi.org/10.1002/nop2.1257
138. U.S. Food and Drug Administration. (2010). Guidance for industry: Characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. U.S. Department of Health and Human Services. https://www.fda.gov/media/78428/download
139. California State University San Marcos. (2012, February 15). CSUSM presents “A conversation with Sonny Lacks,” March 13. https://news.csusm.edu/csusm-presents-a-conversation-with-sonny-lacks-march-13
140. SCHERER, W. F., SYVERTON, J. T., & GEY, G. O. (1953). Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. The Journal of experimental medicine, 97(5), 695–710. https://doi.org/10.1084/jem.97.5.695
141. Peden, K. (2024, March 7). Development of quantitative assays to evaluate the safety of cell substrates and vaccines. U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/science-research-biologics/development-quantitative-assays-evaluate-safety-cell-substrates-and-vaccines
142. Wadman, M. (2023, August 7). What does the historic settlement won by Henrietta Lacks’s family mean for others? Science. https://www.science.org/content/article/what-does-historic-settlement-won-henrietta-lacks-s-family-mean-others
143. Lacks family v. Thermo Fisher Scientific Inc., No. 8:21-cv-02429 (D. Md. 2021). https://www.science.org/do/10.1126/science.adk1834/full/lacksfamily2021lawsuitvsthermofisherscientific.pacer.pdf
144. Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., Choe, H., & Farzan, M. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 426(6965), 450–454. https://doi.org/10.1038/nature02145
145. Nie, Y., Wang, P., Shi, X., Wang, G., Chen, J., Zheng, A., Wang, W., Wang, Z., Qu, X., Luo, M., Tan, L., Song, X., Yin, X., Chen, J., Ding, M., & Deng, H. (2004). Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression. Biochemical and biophysical research communications, 321(4), 994–1000. https://doi.org/10.1016/j.bbrc.2004.07.060
146. Wang, P., Chen, J., Zheng, A., Nie, Y., Shi, X., Wang, W., Wang, G., Luo, M., Liu, H., Tan, L., Song, X., Wang, Z., Yin, X., Qu, X., Wang, X., Qing, T., Ding, M., & Deng, H. (2004). Expression cloning of functional receptor used by SARS coronavirus. Biochemical and biophysical research communications, 315(2), 439–444. https://doi.org/10.1016/j.bbrc.2004.01.076
147. Qu, X. X., Hao, P., Song, X. J., Jiang, S. M., Liu, Y. X., Wang, P. G., Rao, X., Song, H. D., Wang, S. Y., Zuo, Y., Zheng, A. H., Luo, M., Wang, H. L., Deng, F., Wang, H. Z., Hu, Z. H., Ding, M. X., Zhao, G. P., & Deng, H. K. (2005). Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy. The Journal of biological chemistry, 280(33), 29588–29595. https://doi.org/10.1074/jbc.M500662200
148. Ren, W., Qu, X., Li, W., Han, Z., Yu, M., Zhou, P., Zhang, S. Y., Wang, L. F., Deng, H., & Shi, Z. (2008). Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. Journal of virology, 82(4), 1899–1907. https://doi.org/10.1128/JVI.01085-07
149. Ge, X. Y., Li, J. L., Yang, X. L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., Zhang, Y. J., Luo, C. M., Tan, B., Wang, N., Zhu, Y., Crameri, G., Zhang, S. Y., Wang, L. F., Daszak, P., & Shi, Z. L. (2013). Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature, 503(7477), 535–538. https://doi.org/10.1038/nature12711
150. Yang, X. L., Hu, B., Wang, B., Wang, M. N., Zhang, Q., Zhang, W., Wu, L. J., Ge, X. Y., Zhang, Y. Z., Daszak, P., Wang, L. F., & Shi, Z. L. (2015). Isolation and Characterization of a Novel Bat Coronavirus Closely Related to the Direct Progenitor of Severe Acute Respiratory Syndrome Coronavirus. Journal of virology, 90(6), 3253–3256. https://doi.org/10.1128/JVI.02582-15
151. Menachery, V. D., Yount, B. L., Jr, Debbink, K., Agnihothram, S., Gralinski, L. E., Plante, J. A., Graham, R. L., Scobey, T., Ge, X. Y., Donaldson, E. F., Randell, S. H., Lanzavecchia, A., Marasco, W. A., Shi, Z. L., & Baric, R. S. (2015). A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nature medicine, 21(12), 1508–1513. https://doi.org/10.1038/nm.3985
152. Executive Order No. 14,420, 91 Fed. Reg. 53,173 (2026). Delivering gold standard childhood vaccine recommendations for Americans. https://www.federalregister.gov/documents/2026/08/14/2026-16730/delivering-gold-standard-childhood-vaccine-recommendations-for-americans
153. National Institutes of Health, Office of Science Policy. (2022, August). Publications involving HeLa cells. https://osp.od.nih.gov/hela-cells/publications-involving-hela-cells/
154. Autism Librarian (2025, June 16). Trump’s Executive Order: Is Exiting the WHO the Right Thing to Do (for Autism)? https://thecausesofautism.com/2025/06/16/trumps-executive-order-is-exiting-the-who-the-right-thing-to-do-for-autism/
155. Autism Librarian (2026, July 24). Draft Publication- Additional Findings, Deductions, and Pending Research Questions regarding Vaccines. https://thecausesofautism.com/2026/07/24/draft-publication-additional-findings-deductions-and-pending-research-questions-regarding-vaccines/
156. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. (2024, July 25). Contraindications and precautions. https://www.cdc.gov/vaccines/hcp/imz-best-practices/contraindications-precautions.html